Cytyc Corporation Overview |
|
Location
250 Campus DriveMarlborough, MA 01752-3064
United States
Cytyc Corporation Overview
Access the Full Profile for Cytyc Corporation with a Free Trial to the OneSource Business Browser subscription service.
The OneSource Business Browser subscription service includes information such as Executive Bios, Board of Directors, Competition, Company Research, Strategic Initiatives, Strengths & Weaknesses , Corporate Family, Revenue & Sales Data, Financial Analyses & Ratios, Annual Reports, Securities Filings, and more...
Cytyc Corporation Summary
Cytyc Corporation is a leading women's health company that designs, develops, manufactures and markets clinical products for cervical cancer screening, breast cancer risk assessment, treatment of excessive menstrual bleeding and treatment of breast cancer. It products include Novasure, the MammoSite radiation therapy system, the ThinPrep Pap smear test and the FirstCyte Breast Test. Cytyc Surgical Products, located in Palo Alto, Calif., is a wholly owned subsidiary of Cytyc Corporation. This division was formed in March 2004 after Cytyc acquired Novacept, a privately held company with a focus on developing innovative therapeutic devices to improve the quality of women's health care. Based in Marlborough, Mass., Cytyc Corporation's stock is traded on NASDAQ under the symbol CYTC.